Effects of Backward Gait Training With Exoskeleton on Motor Functions
Gait, Hemiplegic, Physical Therapy
About this trial
This is an interventional treatment trial for Gait, Hemiplegic focused on measuring Robotic exoskeleton, Backward gait training, Forward gait training
Eligibility Criteria
Inclusion Criteria:
- 18 years of age or older
- English or Spanish speaking
- A diagnosis first stroke (intracerebral hemorrhage or acute ischemic stroke)
- Referred to Reading Rehabilitation Hospital Outpatient Physical Therapy Clinic (hereafter referred to as outpatient PT)
Exclusion Criteria:
- Unable to follow 1-step commands
- > 220 pounds (100 kg)
- Height < 5'0" or > 6'4"
- Unable to take a few steps with assistance
- A score of > 42/56 on Berg Balance Scale (BBS)
- Prior use of any exoskeleton
- Severe cardiac disease (New York Heart Association Classification IV)
- Severe spasticity (Modified Ashworth score > 3)
- Unstable spine or unhealed pelvic/limb fractures
- Active heterotrophic ossification impacting lower extremity range of motion
- Significant lower or upper extremity contractures
- Inability to achieve neutral ankle dorsiflexion with 12° of knee flexion
- Psychiatric or cognitive issues that could interfere with operating the exoskeleton
- Pregnancy
- Colostomy
- Poor skin integrity in areas in contact with the EksoNRTM
- Unresolved deep vein thrombosis
- Lower limb prosthesis or amputation
- Leg length discrepancies > 0.5 inches for upper legs, 0.75 inches for lower legs
- ROM restrictions preventing normal, reciprocal gait
- Inability to stand for > 60 seconds due to pain or orthostatic hypotension
Sites / Locations
- Sunnyview Rehabilitation Hospital
- Reading Hospital Rehabilitation at WyomissingRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Standard Care with Ekso Group
Standard Care with Ekso and Backward Walking Group
Participants in the SCG (n=31) will attend two 45-minute treatment sessions per week for a minimum of 8 and a maximum of 10 total sessions. For each participant, an individualized plan of care consistent with evidence-based practice standards will be provided based on rehabilitation goals. The interventions during each treatment session will include forward gait training with EksoNR, neuromuscular movement-related tasks, mobility tasks, and interventions using products and technology, and education for caregivers, family, and friends.
Participants in the SCBWG (n=31) will attend two 45-minute treatment sessions per week for a minimum of 8 and a maximum of 10 total sessions. Once a week, each participant will receive standard care as described in the standard care with Ekso group.Once a week, each participant will receive backward walking training with EksoNR during their treatment session.